Related Experiment Video
Updated: Jun 23, 2026
16:59
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Published on: October 10, 2012
[Hepatogenous diabetes - diagnostics and treatment]
F Gundling1, P M Schumm-Draeger, W Schepp
1II. Medizinische Abteilung, Städtisches Krankenhaus München-Bogenhausen. Felix.Gundling@gmx.de
Zeitschrift Fur Gastroenterologie
|May 7, 2009
Summary
Patients with liver cirrhosis often develop hepatogenous diabetes. Management requires careful attention to nutrition and hypoglycemia risk, with specific oral antidiabetics or insulin therapy recommended.
Area of Science:
- Endocrinology
- Hepatology
- Metabolic Disorders
Context:
- Liver cirrhosis frequently leads to glucose metabolism disturbances, including hepatogenous diabetes.
- Hepatocellular dysfunction and insulin resistance are key contributors to these metabolic issues in chronic liver disease.
Purpose:
- To outline current understanding and therapeutic approaches for hepatogenous diabetes in liver cirrhosis patients.
- To highlight the lack of established guidelines for diagnosing and treating this condition.
Summary:
- Hepatogenous diabetes management in cirrhosis necessitates adequate energy and protein intake, considering malnutrition prevalence.
- Pharmacological treatment must carefully weigh hypoglycemia risks; biguanides and PPAR gamma agonists are contraindicated.
- Glinides and short-acting sulfonylureas are suitable oral options, with prandial insulin therapy as a subsequent step if needed.
Impact:
- Optimizing diabetic control in cirrhosis can prevent both typical diabetic complications and cirrhosis-specific issues like gastrointestinal bleeding, hepatic encephalopathy, and hepatocellular carcinoma.
- Establishing clear diagnostic and therapeutic guidelines for hepatogenous diabetes is crucial for improved patient outcomes.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...